A study to evaluate the effect of Kushmanda Modak as an Ahariya Dravya in Urdhwag Amlapitta after 14 days

A randomized controlled trial to evaluate the add-on effect of Kushmanda Modak in Urdhwag Amlapitta as an Ahariya Dravya - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107303

Enrollment

Registered

2026-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

Intervention1: Kushmanda Modak: Medicine Name: Kushmanda Modaka, Reference: Kshemkutuhalam, Route: Oral, Dosage form: Modaka, Dose:10 gm/day,Frequency:OD, Bhaishjya Kal: Pragbhakta, Duration:14 days I

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age group between 19 to 40 years. 2)Irrespective of Gender, caste and religion. 3)Recently diagnosed Patients of Urdhwag Amlapitta having symptoms since 6 months like Utklesha, Tikta-Amlodgar, Aruchi, Gaurav, Hrudkantha Daha. 4)Patient having at least 3 to 4 above mentioned symptoms.

Exclusion criteria

Exclusion criteria: 1)Prolonged use of NSAIDs and antacids. 2)Patient with severe Vomiting, existing gastric ulcer, duodenal ulcer, acid reflux, drug induced hyperacidity and CA Stomach. 3)Patient with Diabetes Mellitus. 4)Pregnant and lactating mothers.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Kushmanda Modak as an Ahariya Dravya in Urdhwag Amlapitta after 14 days Recently Diagnosed patients having Symptoms of: 1)Utklesha (Nausea) 2)Tiktaamlodgara (belching with bitter and sour taste) 3)Gaurav (Feeling of heaviness all over the body) 4)Hrutkanthadaha (Burning sensation in chest and throat) 5)Aruchi (Loss of appetite) Timepoint: 0,7th, 14th day	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Shravani Babar

MAMs Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune

shravanigund@gmail.com9637810884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026